Skip to main content

Vamorolone Side Effects

Medically reviewed by Drugs.com. Last updated on Sep 16, 2023.

Applies to vamorolone: oral suspension.

Warning

Steroids can weaken your immune system, making it easier for you to get an infection, even serious or fatal infections, or worsening an infection you already have. Call your doctor if you have flu symptoms, cough, diarrhea, night sweats, neck stiffness, confusion, or vision problems.

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:

Also call your doctor at once if you have:

Vamorolone can affect growth in children. Tell your doctor if your child is not growing at a normal rate while using this medicine.

Your treatment may be delayed or your dose may be reduced if you have certain side effects.

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For Healthcare Professionals

Applies to vamorolone: oral suspension.

General

The most common adverse reactions occurring in greater than 10% of treated patients included cushingoid features, psychiatric disorders, vomiting, increased weight, and vitamin D deficiency.[Ref]

Cardiovascular

Frequency not reported: Thromboembolic events, elevated blood pressure

Endocrine

Very common (10% or more): Cushingoid features (up to 29%)

Frequency not reported: Pheochromocytoma crisis, increased blood glucose, Cushing's syndrome (hypercortisolism), acute adrenal insufficiency (after abrupt withdrawal)

Gastrointestinal

Very common (10% or more): Vomiting (up to 17%)

Common (1% to 10%): Diarrhea

Frequency not reported: Gastrointestinal perforation

Hematologic

Frequency not reported: Increased lymphocyte and neutrophil counts

Hypersensitivity

Frequency not reported: Anaphylaxis

Immunologic

Frequency not reported: Reduced resistance to new infections

Metabolic

Very common (10% or more): Increased weight (up to 11%), vitamin D deficiency (up to 11%)

Common (1% to 10%): Increased appetite

Frequency not reported: Increased excretion of potassium and calcium, salt and water retention

Musculoskeletal

Frequency not reported: Avascular necrosis, decreased bone formation, increased bone resorption

Nervous system

Common (1% to 10%): Headache

Ocular

Frequency not reported: Posterior subcapsular cataracts

Oncologic

Frequency not reported: Kaposi's sarcoma

Other

Frequency not reported: Activation of latent amebiasis, exacerbation of systemic fungal infections, hepatitis B virus reactivation

Psychiatric

Very common (10% or more): Psychiatric disorders (up to 21%)

Psychiatric disorders included abnormal behavior, aggression, agitation, anxiety, irritability, mood altered, sleep disorder, and stereotypy.

Respiratory

Very common (10% or more): Cough (up to 10%)

Common (1% to 10%): Rhinitis

References

1. Product Information. Agamree (vamorolone). Santhera Pharmaceuticals (US). 2023.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.